SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility amid allegations of a pump-and-dump scheme, sparking intense debate between traders labeling it a fraudulent manipulation and those betting on its potential through upcoming event-driven catalysts. While proponents point to real-world integration and event partnerships as drivers for growth, the community remains deeply polarized over concerns regarding highly concentrated supply ownership and the potential for a sudden, sharp decline.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining significant traction as investors reconnect with its 2011 origin as the original parody token, with community members highlighting its deep historical roots, locked supply, and organic narrative as drivers for potential long-term growth. While some skeptics dismiss it as a joke, proponents are actively comparing it to early memecoin successes and emphasizing its status as a foundational piece of crypto culture that is currently undergoing a massive resurgence.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is generating significant community buzz as traders weigh its potential as an undervalued DeFi leader against broader market volatility and governance-related news. While some participants are actively accumulating on dips in anticipation of a parabolic breakout, others remain focused on technical support levels and ongoing debates regarding its long-term stability compared to other lending protocols.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to a significant policy shift following a new executive order that accelerates FDA review pathways for psychedelic-based therapies, including LSD. Investors are actively debating the potential for a sector-wide re-rating and identifying candidates for future M&A, as Definium remains in focus with multiple Phase 3 trial readouts scheduled throughout the year.

Procure ETF Trust II - Procure Space ETF

The Procure Space ETF ($UFO) is attracting significant community attention as investors position themselves for the potential IPO of SpaceX and the broader expansion of the commercial space economy. While some community members appreciate the ETF for its broad exposure to industry leaders, others are debating whether its diverse holdings truly constitute a 'pure play' on space, leading to discussions about alternative investment strategies.

SuRo Capital Corp. operates as a publicly traded investment fund. It seeks to invest in a broad range of sectors and industries as well as to provide investors with access to such companies through its publicly traded common stock. The company was founded by Mark David Klein on September 17, 2010 and is headquartered in New York, NY.

SuRo Capital Corp

SuRo Capital Corp.

SuRo Capital is trending as investors focus on its concentrated stake in high-growth AI infrastructure companies like CoreWeave and OpenAI, with community sentiment bolstered by potential IPO activity and the firm's portfolio value relative to its NAV. Traders are actively discussing the stock's significant discount to underlying asset value and the impact of upcoming liquidity events, often drawing comparisons to other venture-focused investment vehicles.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently in the spotlight following the announcement of positive Phase 2 signal detection study results for its HLP004 anxiety therapeutic, even as investors grapple with significant volatility and the company's recent rebranding to the "HELP" ticker. Community discourse is sharply divided between long-term holders encouraged by institutional backing and a robust patent portfolio, and skeptical participants highlighting historical dilution concerns and the risks inherent in a clinical-stage biotech navigating a complex regulatory environment.

iShares Trust - iShares MSCI United Kingdom ETF

iShares MSCI United Kingdom ETF

The iShares MSCI United Kingdom ETF is trending as investors monitor ongoing economic instability in the UK, including high inflation and fluctuating political leadership. The community is actively discussing the ETF as a proxy for UK market performance while debating the long-term impacts of fiscal policy and currency volatility on British equities.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently trending due to a wave of sector-wide optimism following a high-profile executive order to fast-track psychedelic research for conditions like PTSD and depression. Investors are actively discussing the potential for accelerated FDA approval timelines, while the community remains focused on the company's progress with its COMP360 therapy and the broader regulatory shift toward psychedelic-assisted treatments.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

The SGOV ETF is trending as investors utilize it as a low-risk "parking lot" for capital amid broad market volatility and economic uncertainty. The community is actively discussing its stability, monthly dividend potential, and its role as a defensive hedge against recessionary fears.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


52-Week High	$5,626.80
Volume	130,225
Contract Size	100 fine troy ounces
Initial Margin	$36,847
Months Traded	Feb, Apr, Jun, Aug, Oct, Dec

52-Week Low	$3,123.30
Exchange	COMEX
Tick	0.10 (10 cents) per troy ounce ($10.00 per contract)
Maintenance Margin	$33,498
Trading Hours	5:00p.m. - 4:00p.m. (Sun-Fri) (Settles 12:30p.m.) CST

GC_F
Gold Futures

Feed

News

Sentiment

Contract Specs

Latest GC_F News

GC_FGold Futures